Liver Cancer
Comparative genomic hybridization tracks the genetics of HCV-related cancer
Published in Cancer Weekly, October 12th, 2004
"To clarify the genetic aberrations involved in the development and progression of hepatitis C virus-associated hepatocellular carcinoma (HCV-HCC), we investigated DNA copy number aberrations (DCNAs) in 19 surgically resected HCCs by conventional comparative genomic hybridization (CGH) and array CGH," scientists in Japan reported.
"Conventional CGH revealed that increases of DNA copy number were frequent at 1q (79% of the cases), 8q (37%), 6p (32%), and 10p (32%) and that decreases were frequent at 17p (79%),16q (58%), 4q (53%),13q (42%), 10q (37%), 1p (32%), and 8p (32%)....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2004-10-12)
More Articles from Cancer Weekly
- Cancer Epidemiology
VDR polymorphisms may heighten prostate cancer risk in African Americans - Endometrial Cancer
Letrozole has limited activity in advanced endometrial cancer - Human Papillomavirus
High-risk HPV oncogene transcripts detected in cervical scrapes - Pulmonary Medicine
CD117 immunoreactivity identifies patients with highly aggressive lung cancers - Adenocarcinomas
hCG lacks specificity for malignant cells to be of clinical use in effusion cytology - Antibody Development
Collaboration to develop fully human antibody therapeutics for cancer - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
